Intradermal drug delivery is increasingly recognized as a potential solution to many of the challenges faced by new and existing medicines. Intradermal dosing provides the opportunity to more effectively administer agents such as small molecules, biologics, and vaccines, allowing for improved bioavailability. Nonetheless, the widespread use of this route of administration continues to be limited by technical challenges in the performing of intradermal injections, which requires specialized training and has poor reproducibility.
Market Analysis and Insights: Global Microneedle Drug Delivery Systems Market
In 2019, the global Microneedle Drug Delivery Systems market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Microneedle Drug Delivery Systems Scope and Market Size
Microneedle Drug Delivery Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Microneedle Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Microneedle Drug Delivery Systems market is segmented into Hollow Microneedle Technology, Solid Microneedle Technology, Dissolving Microneedles Technology, etc.
Segment by Application, the Microneedle Drug Delivery Systems market is segmented into Drug Delivery, Vaccine Delivery, Other, etc.
Regional and Country-level Analysis
The Microneedle Drug Delivery Systems market is analysed and market size information is provided by regions (countries).
The key regions covered in the Microneedle Drug Delivery Systems market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape and Microneedle Drug Delivery Systems Market Share Analysis
Microneedle Drug Delivery Systems market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Microneedle Drug Delivery Systems business, the date to enter into the Microneedle Drug Delivery Systems market, Microneedle Drug Delivery Systems product introduction, recent developments, etc.
The major vendors include 3M, Zosano Pharma, Becton-Dickinson?BD?Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Vaxxas, Lohmann Therapie-Systeme AG, etc.
This report focuses on the global Microneedle Drug Delivery Systems status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Microneedle Drug Delivery Systems development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
3M
Zosano Pharma
Becton-Dickinson?BD?Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect
Vaxxas
Lohmann Therapie-Systeme AG
Market segment by Type, the product can be split into
Hollow Microneedle Technology
Solid Microneedle Technology
Dissolving Microneedles Technology
Market segment by Application, split into
Drug Delivery
Vaccine Delivery
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Microneedle Drug Delivery Systems status, future forecast, growth opportunity, key market and key players.
To present the Microneedle Drug Delivery Systems development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Microneedle Drug Delivery Systems are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Microneedle Drug Delivery Systems Revenue
1.4 Market Analysis by Type
1.4.1 Global Microneedle Drug Delivery Systems Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hollow Microneedle Technology
1.4.3 Solid Microneedle Technology
1.4.4 Dissolving Microneedles Technology
1.5 Market by Application
1.5.1 Global Microneedle Drug Delivery Systems Market Share by Application: 2020 VS 2026
1.5.2 Drug Delivery
1.5.3 Vaccine Delivery
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Microneedle Drug Delivery Systems Market Perspective (2015-2026)
2.2 Microneedle Drug Delivery Systems Growth Trends by Regions
2.2.1 Microneedle Drug Delivery Systems Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Microneedle Drug Delivery Systems Historic Market Share by Regions (2015-2020)
2.2.3 Microneedle Drug Delivery Systems Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Microneedle Drug Delivery Systems Market Growth Strategy
2.3.6 Primary Interviews with Key Microneedle Drug Delivery Systems Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Microneedle Drug Delivery Systems Players by Market Size
3.1.1 Global Top Microneedle Drug Delivery Systems Players by Revenue (2015-2020)
3.1.2 Global Microneedle Drug Delivery Systems Revenue Market Share by Players (2015-2020)
3.1.3 Global Microneedle Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Microneedle Drug Delivery Systems Market Concentration Ratio
3.2.1 Global Microneedle Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Microneedle Drug Delivery Systems Revenue in 2019
3.3 Microneedle Drug Delivery Systems Key Players Head office and Area Served
3.4 Key Players Microneedle Drug Delivery Systems Product Solution and Service
3.5 Date of Enter into Microneedle Drug Delivery Systems Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Microneedle Drug Delivery Systems Historic Market Size by Type (2015-2020)
4.2 Global Microneedle Drug Delivery Systems Forecasted Market Size by Type (2021-2026)
5 Microneedle Drug Delivery Systems Breakdown Data by Application (2015-2026)
5.1 Global Microneedle Drug Delivery Systems Market Size by Application (2015-2020)
5.2 Global Microneedle Drug Delivery Systems Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Microneedle Drug Delivery Systems Market Size (2015-2020)
6.2 Microneedle Drug Delivery Systems Key Players in North America (2019-2020)
6.3 North America Microneedle Drug Delivery Systems Market Size by Type (2015-2020)
6.4 North America Microneedle Drug Delivery Systems Market Size by Application (2015-2020)
7 Europe
7.1 Europe Microneedle Drug Delivery Systems Market Size (2015-2020)
7.2 Microneedle Drug Delivery Systems Key Players in Europe (2019-2020)
7.3 Europe Microneedle Drug Delivery Systems Market Size by Type (2015-2020)
7.4 Europe Microneedle Drug Delivery Systems Market Size by Application (2015-2020)
8 China
8.1 China Microneedle Drug Delivery Systems Market Size (2015-2020)
8.2 Microneedle Drug Delivery Systems Key Players in China (2019-2020)
8.3 China Microneedle Drug Delivery Systems Market Size by Type (2015-2020)
8.4 China Microneedle Drug Delivery Systems Market Size by Application (2015-2020)
9 Japan
9.1 Japan Microneedle Drug Delivery Systems Market Size (2015-2020)
9.2 Microneedle Drug Delivery Systems Key Players in Japan (2019-2020)
9.3 Japan Microneedle Drug Delivery Systems Market Size by Type (2015-2020)
9.4 Japan Microneedle Drug Delivery Systems Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Microneedle Drug Delivery Systems Market Size (2015-2020)
10.2 Microneedle Drug Delivery Systems Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Microneedle Drug Delivery Systems Market Size by Type (2015-2020)
10.4 Southeast Asia Microneedle Drug Delivery Systems Market Size by Application (2015-2020)
11 India
11.1 India Microneedle Drug Delivery Systems Market Size (2015-2020)
11.2 Microneedle Drug Delivery Systems Key Players in India (2019-2020)
11.3 India Microneedle Drug Delivery Systems Market Size by Type (2015-2020)
11.4 India Microneedle Drug Delivery Systems Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Microneedle Drug Delivery Systems Market Size (2015-2020)
12.2 Microneedle Drug Delivery Systems Key Players in Central & South America (2019-2020)
12.3 Central & South America Microneedle Drug Delivery Systems Market Size by Type (2015-2020)
12.4 Central & South America Microneedle Drug Delivery Systems Market Size by Application (2015-2020)
13Key Players Profiles
13.1 3M
13.1.1 3M Company Details
13.1.2 3M Business Overview and Its Total Revenue
13.1.3 3M Microneedle Drug Delivery Systems Introduction
13.1.4 3M Revenue in Microneedle Drug Delivery Systems Business (2015-2020))
13.1.5 3M Recent Development
13.2 Zosano Pharma
13.2.1 Zosano Pharma Company Details
13.2.2 Zosano Pharma Business Overview and Its Total Revenue
13.2.3 Zosano Pharma Microneedle Drug Delivery Systems Introduction
13.2.4 Zosano Pharma Revenue in Microneedle Drug Delivery Systems Business (2015-2020)
13.2.5 Zosano Pharma Recent Development
13.3 Becton-Dickinson?BD?Technologies
13.3.1 Becton-Dickinson?BD?Technologies Company Details
13.3.2 Becton-Dickinson?BD?Technologies Business Overview and Its Total Revenue
13.3.3 Becton-Dickinson?BD?Technologies Microneedle Drug Delivery Systems Introduction
13.3.4 Becton-Dickinson?BD?Technologies Revenue in Microneedle Drug Delivery Systems Business (2015-2020)
13.3.5 Becton-Dickinson?BD?Technologies Recent Development
13.4 Nanopass Technologies
13.4.1 Nanopass Technologies Company Details
13.4.2 Nanopass Technologies Business Overview and Its Total Revenue
13.4.3 Nanopass Technologies Microneedle Drug Delivery Systems Introduction
13.4.4 Nanopass Technologies Revenue in Microneedle Drug Delivery Systems Business (2015-2020)
13.4.5 Nanopass Technologies Recent Development
13.5 Corium
13.5.1 Corium Company Details
13.5.2 Corium Business Overview and Its Total Revenue
13.5.3 Corium Microneedle Drug Delivery Systems Introduction
13.5.4 Corium Revenue in Microneedle Drug Delivery Systems Business (2015-2020)
13.5.5 Corium Recent Development
13.6 Valeritas
13.6.1 Valeritas Company Details
13.6.2 Valeritas Business Overview and Its Total Revenue
13.6.3 Valeritas Microneedle Drug Delivery Systems Introduction
13.6.4 Valeritas Revenue in Microneedle Drug Delivery Systems Business (2015-2020)
13.6.5 Valeritas Recent Development
13.7 Nitto
13.7.1 Nitto Company Details
13.7.2 Nitto Business Overview and Its Total Revenue
13.7.3 Nitto Microneedle Drug Delivery Systems Introduction
13.7.4 Nitto Revenue in Microneedle Drug Delivery Systems Business (2015-2020)
13.7.5 Nitto Recent Development
13.8 Microdermics
13.8.1 Microdermics Company Details
13.8.2 Microdermics Business Overview and Its Total Revenue
13.8.3 Microdermics Microneedle Drug Delivery Systems Introduction
13.8.4 Microdermics Revenue in Microneedle Drug Delivery Systems Business (2015-2020)
13.8.5 Microdermics Recent Development
13.9 TheraJect
13.9.1 TheraJect Company Details
13.9.2 TheraJect Business Overview and Its Total Revenue
13.9.3 TheraJect Microneedle Drug Delivery Systems Introduction
13.9.4 TheraJect Revenue in Microneedle Drug Delivery Systems Business (2015-2020)
13.9.5 TheraJect Recent Development
13.10 Vaxxas
13.10.1 Vaxxas Company Details
13.10.2 Vaxxas Business Overview and Its Total Revenue
13.10.3 Vaxxas Microneedle Drug Delivery Systems Introduction
13.10.4 Vaxxas Revenue in Microneedle Drug Delivery Systems Business (2015-2020)
13.10.5 Vaxxas Recent Development
13.11 Lohmann Therapie-Systeme AG
10.11.1 Lohmann Therapie-Systeme AG Company Details
10.11.2 Lohmann Therapie-Systeme AG Business Overview and Its Total Revenue
10.11.3 Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Introduction
10.11.4 Lohmann Therapie-Systeme AG Revenue in Microneedle Drug Delivery Systems Business (2015-2020)
10.11.5 Lohmann Therapie-Systeme AG Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Research Methodology
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.